These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 6722733
1. Neuroblastoma. Mass screening for early detection and its prognosis. Sawada T, Kidowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M, Kusunoki T. Cancer; 1984 Jun 15; 53(12):2731-5. PubMed ID: 6722733 [Abstract] [Full Text] [Related]
3. Mass screening for neuroblastoma in Japan. Sawada T, Sugimoto T, Kawakatsu H, Matsumura T, Matsuda Y. Pediatr Hematol Oncol; 1991 Jun 15; 8(2):93-109. PubMed ID: 1863547 [Abstract] [Full Text] [Related]
4. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group. Sawada T, Hirayama M, Nakata T, Takeda T, Takasugi N, Mori T, Maeda K, Koide R, Hanawa Y, Tsunoda A. Lancet; 1984 Aug 04; 2(8397):271-3. PubMed ID: 6146820 [Abstract] [Full Text] [Related]
5. Imaging evaluation of infants with neuroblastoma detected by VMA screening spot test. Fujioka M, Saiki N, Aihara T, Yamamoto K. Pediatr Radiol; 1988 Aug 04; 18(6):479-83. PubMed ID: 3054769 [Abstract] [Full Text] [Related]
6. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society]. Sawada T, Nagahara N, Ohi R, Yamamoto K, Okabe I, Hanawa Y, Hashizume K, Matsui I, Ohkawa H, Tunoda A. Gan To Kagaku Ryoho; 1990 Dec 04; 17(12):2319-26. PubMed ID: 2260868 [Abstract] [Full Text] [Related]
8. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects. Sawada T, Sugimoto T, Tanaka T, Kawakatsu H, Ishii T, Matsumura T, Horii Y. Med Pediatr Oncol; 1987 Dec 04; 15(1):14-7. PubMed ID: 3561327 [Abstract] [Full Text] [Related]
10. Mass screening of neuroblastoma in infancy. Sawada T, Todo S, Fujita K, Iino S, Imashuku S, Kusunoki T. Am J Dis Child; 1982 Aug 04; 136(8):710-2. PubMed ID: 6808827 [Abstract] [Full Text] [Related]
11. Incidence of neuroblastoma in infancy in Japan. Sawada T, Kidowaki T, Sugimoto T, Kusunoki T. Med Pediatr Oncol; 1984 Aug 04; 12(2):101-3. PubMed ID: 6700544 [Abstract] [Full Text] [Related]
13. VMA mass screening program of neuroblastoma for infants in Nagoya City, Japan. Kodama K, Nakata T, Ishii J, Mitani K, Tsunooka H, Masaoka A, Aoyama M. Am J Public Health; 1985 Feb 04; 75(2):173-5. PubMed ID: 3966625 [Abstract] [Full Text] [Related]
14. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions. Suita S. J Pediatr Surg; 2002 Jul 04; 37(7):949-54. PubMed ID: 12077747 [Abstract] [Full Text] [Related]
15. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds. Hayashi Y, Ohi R, Yaoita S, Nakamura M, Kikuchi Y, Konno T, Tsuchiya S, Shiraishi H. J Pediatr Surg; 1995 Mar 04; 30(3):467-70. PubMed ID: 7760244 [Abstract] [Full Text] [Related]
17. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan. Yamamoto K, Hayashi Y, Hanada R, Kikuchi A, Ichikawa M, Tanimura M, Yoshioka S. J Clin Oncol; 1995 Aug 04; 13(8):2033-8. PubMed ID: 7636545 [Abstract] [Full Text] [Related]
18. Past and future of neuroblastoma screening in Japan. Sawada T. Am J Pediatr Hematol Oncol; 1992 Nov 04; 14(4):320-6. PubMed ID: 1456397 [Abstract] [Full Text] [Related]